Back
ProQR Therapeutics NV Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
49
PRQR
ProQR Therapeutics NV
Last Price:
$2.13
Seasonality Move:
13.33%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.15 | Sell |
| 20-day SMA: | 2.15 | Sell |
| 50-day SMA: | 2.37 | Sell |
| 200-day SMA: | 2.03 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.18 | Sell |
| 50-day EMA: | 1.93 | Buy |
| 200-day EMA: | 0.86 | Buy |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.08 | Sell |
| Chaikin Money Flow: | 539265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ProQR Therapeutics NV Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.01 while PRQR 8-day simple moving average is 2.15, which is a Sell signal.
-
The stock price of PRQR is 2.01 while ProQR Therapeutics NV 20-day SMA is 2.15, which makes it a Sell.
-
ProQR Therapeutics NV 50-day simple moving average is 2.37 while PRQR share price is 2.01, making it a Sell technically.
-
PRQR stock price is 2.01 and ProQR Therapeutics NV 200-day simple moving average is 2.03, creating a Sell signal.
PRQR Technical Analysis vs Fundamental Analysis
Sell
49
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a SellThe current ProQR Therapeutics NV [PRQR] share price is $2.01. The Score for PRQR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
211.7M
Price in USD:
2.01
Share Volume:
659.1K
ProQR Therapeutics NV 52-Week Range
52-Week High:
3.71
52-Week Low:
1.07
Sell
49
ProQR Therapeutics NV (PRQR)
is a Sell
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?The ProQR Therapeutics NV stock price is 2.01 USD today.
-
Will PRQR stock go up or go down?ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators
-
Is ProQR Therapeutics NV overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is overvalued.
Is ProQR Therapeutics NV Stock a Buy?
-
ProQR Therapeutics NV share price is 2.01 while PRQR 8-day exponential moving average is 2.11, which is a Sell signal.
-
The stock price of PRQR is 2.01 while ProQR Therapeutics NV 20-day EMA is 2.18, which makes it a Sell.
-
ProQR Therapeutics NV 50-day exponential moving average is 1.93 while PRQR share price is 2.01, making it a Buy technically.
-
PRQR stock price is 2.01 and ProQR Therapeutics NV 200-day simple moving average is 0.86, creating a Buy signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.08 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
-
PRQR Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting ProQR Therapeutics NV is a Sell
-
ProQR Therapeutics NV Relative Strength Index (RSI) is 40.08, which suggest ProQR Therapeutics NV is oversold
-
The Bollinger Bands (25) for ProQR Therapeutics NV is ( - ), which suggest ProQR Therapeutics NV is a Buy
-
The Bollinger Bands (100) for ProQR Therapeutics NV is ( - ), which suggest ProQR Therapeutics NV is a Buy
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.